Provided by Tiger Trade Technology Pte. Ltd.

Kura Oncology

8.58
+0.09001.06%
Volume:1.19M
Turnover:10.16M
Market Cap:746.61M
PE:-3.46
High:8.66
Open:8.41
Low:8.36
Close:8.49
52wk High:12.49
52wk Low:5.41
Shares:87.02M
Float Shares:63.99M
Volume Ratio:0.71
T/O Rate:1.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4801
EPS(LYR):-2.0193
ROE:-65.10%
ROA:-26.57%
PB:3.08
PE(LYR):-4.25

Loading ...

Kura Oncology (KURA) Gets a Buy from Wedbush

TIPRANKS
·
Feb 16

Kura Oncology reports inducement grants under Nasdaq listing rule

TIPRANKS
·
Feb 06

Kura Oncology Grants Stock Options to New Employees Under Inducement Plan

Reuters
·
Feb 06

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Feb 06

Barclays Remains a Buy on Kura Oncology (KURA)

TIPRANKS
·
Feb 04

Kura Oncology Tightens Governance with Amended Bylaws

TIPRANKS
·
Jan 30

Kura Oncology SVP Thomas James Doyle Disposes of Common Shares

Reuters
·
Jan 28

Kura Oncology Chief Medical Officer Mollie Leoni Reports Sale of Common Shares

Reuters
·
Jan 28

Analysts’ Top Healthcare Picks: Kura Oncology (KURA), UnitedHealth (UNH)

TIPRANKS
·
Jan 28

Kura Oncology price target lowered to $20 from $25 at Leerink

TIPRANKS
·
Jan 13

Kura Oncology Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
Jan 13

Kura Oncology Inc : Leerink Partners Cuts Target Price to $20 From $25

THOMSON REUTERS
·
Jan 13

Barclays Sticks to Its Buy Rating for Kura Oncology (KURA)

TIPRANKS
·
Jan 13

Kura Oncology Unveils Precision Medicine Advances and Pipeline Expansion in New Corporate Presentation

Reuters
·
Jan 13

Analysts Offer Insights on Healthcare Companies: Cerus (CERS) and Kura Oncology (KURA)

TIPRANKS
·
Jan 12

Kura Oncology projects $45M–$55M in non-cash collaboration revenue for 2026

Reuters
·
Jan 12

Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones

GlobeNewswire
·
Jan 12

Kura Oncology Grants Stock Options to New Employees Under Inducement Plan

Reuters
·
Jan 05

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jan 05

Kura Oncology Chief Scientific Officer Francis Burrows Reports Disposal of Common Shares

Reuters
·
Dec 20, 2025